City of Enid v. Purdue Pharma LP et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:19-op-45717 |
| Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
| Cause | 28:1332 Diversity-Petition for Removal |
| Case Filed: | Aug 23, 2019 |
| Case in other court: | Oklahoma Western, 5:19-cv-00351 |
| Last checked: Friday Nov 08, 2019 8:14 PM EST |
|
*** SELECTION REQUIRED
L. & R. Distributors, Inc., doing business as SAJ Distributors
|
|
|
*** SELECTION REQUIRED
Mylan Pharmaceuticals, Inc.
781 Chestnut Ridge Road
Morgantown, WV 26505 |
|
|
*** SELECTION REQUIRED
Sandoz, Inc.
|
|
|
*** SELECTION REQUIRED
Par Pharmaceutical Inc.
|
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Keysource Medical, Inc.
|
|
|
Defendant
Mallinckrodt LLC
|
Represented By
|
|
Defendant
Mallinckrodt PLC
|
Represented By
|
|
Defendant
McKesson Corp.
|
Represented By
|
|
Defendant
Morris & Dickson Co LLC
|
|
|
Defendant
Ortho-McNeil Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Physicians Total Care Inc
|
|
|
Defendant
Purdue Frederick Company, The
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Quest Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
TEVA Pharmaceuticals USA Inc
3411 Silverside Road
Wilmington, DE 19180 |
Represented By
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
|
Defendant
Walgreens Boots Alliance Inc.
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Watson Pharma, Inc.
|
|
|
Defendant
Watson Pharmaceutcals, Inc.
|
Represented By
|
|
Defendant
Lynn Webster
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis plc
|
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Amerisourcebergen Corp.
|
Represented By
|
|
Defendant
Anda Inc
|
Represented By
|
|
Defendant
Anda Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
CVS Health Corporation
|
Represented By
|
|
Defendant
CVS Pharmacy Inc.
|
Represented By
|
|
Defendant
CVS Pharmacy, Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Perry Fine
|
Represented By
|
|
Defendant
GCP Pharma LLC
|
|
|
Defendant
Harvard Drug Group LLC The
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Plaintiff
City of Enid
|
Represented By
|
| Docket last updated: 08/26/2019 12:25 PM EDT |
| Wednesday, April 17, 2019 | ||
| 1 | 1
NOTICE OF REMOVAL from District Court of Garfield County, case number CJ-2019-63 filed by Actavis LLC.(ac) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - Transfer Order,
|
||
|
Att: 2
Exhibit 2 - Service of Process Notice,
|
||
|
Att: 3
Exhibit 3 - Docket Sheet,
|
||
|
Att: 4
Exhibit 4 - Petition,
|
||
|
Att: 5
Exhibit 5 - Summons to Actavis LLC,
|
||
|
Att: 6
Exhibit 6 - Summons to Actavis Pharma,
|
||
|
Att: 7
Exhibit 7 - Summons to Actavis PLC,
|
||
|
Att: 8
Exhibit 8 - Summons to Allergan,
|
||
|
Att: 9
Exhibit 9 - Summons to AmerisourceBergen Corp,
|
||
|
Att: 10
Exhibit 10 - Summons to Anda Pharmaceuticals,
|
||
|
Att: 11
Exhibit 11 - Summons to Anda,
|
||
|
Att: 12
Exhibit 12 - Summons to Cardinal Health,
|
||
|
Att: 13
Exhibit 13 - Summons to Cephalon,
|
||
|
Att: 14
Exhibit 14 - Summons to CVS Health Corporation,
|
||
|
Att: 15
Exhibit 15 - Summons to CVS Pharmacy,
|
||
|
Att: 16
Exhibit 16 - Summons to Endo Health Solutions,
|
||
|
Att: 17
Exhibit 17 - Summons to Endo Pharmaceuticals,
|
||
|
Att: 18
Exhibit 18 - Summons to Harvard Drug Group,
|
||
|
Att: 19
Exhibit 19 - Summons to Insys Therapeutic,
|
||
|
Att: 20
Exhibit 20 - Summons to Janssen Pharmaceutica,
|
||
|
Att: 21
Exhibit 21 - Summons to Janssen Pharmaceuticals,
|
||
|
Att: 22
Exhibit 22 - Summons to Johnson & Johnson,
|
||
|
Att: 23
Exhibit 23 - Summons to Keysource Medical,
|
||
|
Att: 24
Exhibit 24 - Summons to Lynn Webster, M.D,
|
||
|
Att: 25
Exhibit 25 - Summons to Mallinckrodt LLC,
|
||
|
Att: 26
Exhibit 26 - Summons to Mallinckrodt PLC,
|
||
|
Att: 27
Exhibit 27 - Summons to McKesson Corp,
|
||
|
Att: 28
Exhibit 28 - Summons to Morris & Dickson Co,
|
||
|
Att: 29
Exhibit 29 - Summons to Oklahoma CVS Pharmacy,
|
||
|
Att: 30
Exhibit 30 - Summons to Ortho-McNeil-Janssen Pharmaceuticals,
|
||
|
Att: 31
Exhibit 31 - Summons to Perry Fine, M.D,
|
||
|
Att: 32
Exhibit 32 - Summons to Physicians Total Care,
|
||
|
Att: 33
Exhibit 33 - Summons to Purdue Frederick Company,
|
||
|
Att: 34
Exhibit 34 - Summons to Purdue Pharma Inc,
|
||
|
Att: 35
Exhibit 35 - Summons to Purdue Pharma L.P,
|
||
|
Att: 36
Exhibit 36 - Summons to Quest Pharmaceuticals,
|
||
|
Att: 37
Exhibit 37 - Summons to Teva Pharmaceuticals USA,
|
||
|
Att: 38
Exhibit 38 - Summons to Walgreen Co,
|
||
|
Att: 39
Exhibit 39 - Summons to Watson Laboratories,
|
||
|
Att: 40
Exhibit 40 - Summons to Watson Pharma,
|
||
|
Att: 41
Exhibit 41 - Summons to Watson Pharmaceuticals,
|
||
|
Att: 42
Exhibit 42 - Campbell Entry of Appearance obo McKesson Corporation,
|
||
|
Att: 43
Exhibit 43 - McBride and Huntsman Entry of Appearance obo AmerisourceBergen,
|
||
|
Att: 44
Exhibit 44 - Quinn Entry of Appearance obo Anda,
|
||
|
Att: 45
Exhibit 45 - Ray Entry of Appearance obo Cardinal Health,
|
||
|
Att: 46
Exhibit 46 - Ray Entry of Appearance obo Harvard Drug Group,
|
||
|
Att: 47
Exhibit 47 - Riddles Entry of Appearance obo Quest Pharmaceuticals,
|
||
|
Att: 48
Exhibit 48 - Defendant Quest Pharmaceuticals Unopposed Motion for Enlargement of Time to Answer,
|
||
|
Att: 49
Exhibit 49 - Defendants Anda Unopposed Motion for Enlargement of Time to Answer,
|
||
|
Att: 50
Exhibit 50 - Defendants CVS and Walgreen Unopposed Motion for Enlargement of Time to Answer,
|
||
|
Att: 51
Exhibit 51 - Defendants Unopposed Motion for Enlargement of Time to Answer,
|
||
|
Att: 52
Exhibit 52 - Manufacturer Defendants Unopposed Motion for Extension of Time,
|
||
|
Att: 53
Exhibit 53 - Order Granting Defendant Quest Motion for Enlargement of Time to Answer,
|
||
|
Att: 54
Exhibit 54 - Order Granting Defendants Anda Motion for Enlargement of Time to Answer,
|
||
|
Att: 55
Exhibit 55 - Order Granting Defendants CVS and Walgreen Unopposed Motion for Enlargement of Time to Answer,
|
||
|
Att: 56
Exhibit 56 - Order Granting Defendants Unopposed Motion for Enlargement of Time to Answer,
|
||
|
Att: 57
Exhibit 57 - Order Granting Manufacturer Defendants Extension of Time,
|
||
|
Att: 58
Civil Cover Sheet
|
||
| Thursday, April 18, 2019 | ||
| PAYMENT FOR A CIVIL CASE Notice of Removal Filing fee $ 400, receipt number 1087-2904763. (Evans, Kyle) [Transferred from okwd on 8/23/2019.] | ||
| 2 | 2
ENTRY of Appearance by Ryan A Ray on behalf of Cardinal Health Inc (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| 3 | 3
ENTRY of Appearance by Ryan A Ray on behalf of Harvard Drug Group LLC The (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| 4 | 4
DISCLOSURE STATEMENT - CORPORATE by Cardinal Health Inc . (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| 5 | 5
DISCLOSURE STATEMENT - LLC by Harvard Drug Group LLC The . (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| 6 | 6
ENTRY of Appearance by Susan E Huntsman on behalf of Amerisourcebergen Corp (Huntsman, Susan) [Transferred from okwd on 8/23/2019.]
|
|
| 7 | 7
DISCLOSURE STATEMENT - CORPORATE by Amerisourcebergen Corp . (Huntsman, Susan) [Transferred from okwd on 8/23/2019.]
|
|
| 8 | 8
ENTRY of Appearance by D Michael McBride, III on behalf of Amerisourcebergen Corp (McBride, D) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, April 19, 2019 | ||
| 9 | 9
ENTRY of Appearance by Stuart D Campbell on behalf of McKesson Corp (Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
| 10 | 10
DISCLOSURE STATEMENT - CORPORATE by McKesson Corp . (Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
| 11 | 11
ENTRY of Appearance by Nicholas V Merkley on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (Merkley, Nicholas) [Transferred from okwd on 8/23/2019.]
|
|
| 12 | 12
ENTRY of Appearance by Kyle D Evans on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (Evans, Kyle) [Transferred from okwd on 8/23/2019.]
|
|
| 13 | 13
ENTRY of Appearance by Robert G McCampbell on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (McCampbell, Robert) [Transferred from okwd on 8/23/2019.]
|
|
| 14 | 14
DISCLOSURE STATEMENT - CORPORATE by Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc . (McCampbell, Robert) [Transferred from okwd on 8/23/2019.]
|
|
| 15 | 15
SUPPLEMENTAL Notice of Removal by McKesson Corp.(Campbell, Stuart) Modified on 4/19/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - Docket,
|
||
|
Att: 2
Exhibit 2 - Petition,
|
||
|
Att: 3
Exhibit 3 - Summonses,
|
||
|
Att: 4
Exhibit 4 - Appearance - AmerisourceBergen,
|
||
|
Att: 5
Exhibit 5 - Appearance - Cardinal,
|
||
|
Att: 6
Exhibit 6 - Appearance - Harvard Drug,
|
||
|
Att: 7
Exhibit 7 - Appearance - McKesson,
|
||
|
Att: 8
Exhibit 8 - Motion for Enlargement - McKesson,
|
||
|
Att: 9
Exhibit 9 - Order Granting Motion for Enlargement - McKesson,
|
||
|
Att: 10
Exhibit 10 - Appearance - Quest,
|
||
|
Att: 11
Exhibit 11 - Motion for Enlargement - Quest,
|
||
|
Att: 12
Exhibit 12 - Order Granting Motion for Enlargement - CVS,
|
||
|
Att: 13
Exhibit 13 - Order Granting Motion for Enlargement - Quest,
|
||
|
Att: 14
Exhibit 14 - Motion for Enlargement - CVS,
|
||
|
Att: 15
Exhibit 15 - Appearance - Anda,
|
||
|
Att: 16
Exhibit 16 - Motion for Enlargement - Anda,
|
||
|
Att: 17
Exhibit 17 - Order Granting Enlargement - Manufacturers,
|
||
|
Att: 18
Exhibit 18 - Motion for Extension - Manufacturers,
|
||
|
Att: 19
Exhibit 19 - Order Granting Enlargement - Anda,
|
||
|
Att: 20
Exhibit 20 - LCvR7.1
|
||
| 16 | 16
ENTRY of Appearance by Sara E Potts on behalf of McKesson Corp (Potts, Sara) [Transferred from okwd on 8/23/2019.]
|
|
| Monday, April 22, 2019 | ||
| 17 | 17
UNOPPOSED MOTION for Extension of Time to File Answer Move or Otherwise Respond to Petition Under Rule 12 by Amerisourcebergen Corp, Cardinal Health Inc, Harvard Drug Group LLC The, McKesson Corp. (Campbell, Stuart) Modified on 4/22/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
| 18 | 18
ENTRY of Appearance by Raymond E Zschiesche on behalf of Endo Health Solutions Inc, Endo Pharmaceuticals Inc (Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.]
|
|
| 19 | 19
ENTRY of Appearance by Jeffrey A Curran on behalf of Anda Inc, Anda Pharmaceuticals Inc (Curran, Jeffrey) [Transferred from okwd on 8/23/2019.]
|
|
| 20 | 20
ENTRY of Appearance by Ashley E Quinn on behalf of Anda Inc, Anda Pharmaceuticals Inc (Quinn, Ashley) [Transferred from okwd on 8/23/2019.]
|
|
| 21 | 21
DISCLOSURE STATEMENT - CORPORATE by Anda Inc, Anda Pharmaceuticals Inc . (Quinn, Ashley) [Transferred from okwd on 8/23/2019.]
|
|
| 22 | 22
ENTRY of Appearance by William A Johnson on behalf of Watson Pharmaceutical Inc (Johnson, William) [Transferred from okwd on 8/23/2019.]
|
|
| 23 | 23
ENTRY of Appearance by Elizabeth A Price on behalf of Watson Pharmaceutical Inc (Price, Elizabeth) [Transferred from okwd on 8/23/2019.]
|
|
| 24 | 24
UNOPPOSED MOTION for Extension of Time to File Responsive Pleading by Watson Pharmaceutical Inc. (Johnson, William) [Transferred from okwd on 8/23/2019.]
|
|
| 25 | 25
DISCLOSURE STATEMENT - CORPORATE by Endo Health Solutions Inc . (Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.]
|
|
| 26 | 26
DISCLOSURE STATEMENT - CORPORATE by Endo Pharmaceuticals Inc . (Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.]
|
|
| Tuesday, April 23, 2019 | ||
| 27 | 27
ORDER granting17 Defendants McKesson Corporation, Cardinal Health, Inc., The Harvard Drug Group, LLC and AmerisourceBergen Corporation's Unopposed Joint Motion to Extend Time to Answer, Move or Otherwise Respond to Petition Under Rule 12. Signed by Honorable Stephen P. Friot on 4/23/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| 28 | 28
ORDER granting24 Defendant Allergan Finance, LLC, f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc.'s Unopposed Motion for Extension of Time to File Responsive Pleadings. Signed by Honorable Stephen P. Friot on 4/23/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| 29 | 29
ENTRY of Appearance by D Todd Riddles on behalf of Quest Pharmaceuticals Inc (Riddles, D) [Transferred from okwd on 8/23/2019.]
|
|
| 30 | 30
DISCLOSURE STATEMENT - CORPORATE by Quest Pharmaceuticals Inc . (Riddles, D) [Transferred from okwd on 8/23/2019.]
|
|
| 31 | 31
UNOPPOSED MOTION for Extension of Time to File Answer , Move or Otherwise Respond to Petition Under Rule 12 by Quest Pharmaceuticals Inc. (Riddles, D) Modified on 4/24/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
| Wednesday, April 24, 2019 | ||
| 32 | 32
ORDER granting31 Quest Pharmaceuticals, Inc.'s Unopposed Motion to Extend Time to Answer, Move or Otherwise Respond to Petition Under Rule 12. Signed by Honorable Stephen P. Friot on 4/24/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| 33 | 33
UNOPPOSED MOTION for Extension of Time to File Answer Move to Dismiss or Otherwise Respond to Plaintiff's Petition Under Rule 12 by CVS Health Corporation, CVS Pharmacy Inc, CVS Pharmacy LLC, Walgreens Boots Alliance Inc. (White, Amy) Modified on 4/24/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
| 34 | 34
ORDER granting33 Defendants CVS Health Corporation, CVS Pharmacy, Inc., Oklahoma CVS Pharmacy L.L.C., and Walgreens Boots Alliance, Inc. a/k/a Walgreen Co.'s Unopposed Motion to Extend Time to Answer, Move to Dismiss or Otherwise Respond to Plaintiff's Petition Under Rule 12. Signed by Honorable Stephen P. Friot on 4/24/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| Thursday, April 25, 2019 | ||
| 35 | 35
ENTRY of Appearance by Sanford C Coats on behalf of The Purdue Frederick Company, Purdue Pharma Inc, Purdue Pharma LP (Coats, Sanford) [Transferred from okwd on 8/23/2019.]
|
|
| 36 | 36
ENTRY of Appearance by Joshua D Burns on behalf of The Purdue Frederick Company, Purdue Pharma Inc, Purdue Pharma LP (Burns, Joshua) [Transferred from okwd on 8/23/2019.]
|
|
| 37 | 37
ENTRY of Appearance by Jennifer N Lamirand on behalf of The Purdue Frederick Company, Purdue Pharma Inc, Purdue Pharma LP (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| 38 | 38
DISCLOSURE STATEMENT - LLC by Purdue Pharma LP . (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| 39 | 39
DISCLOSURE STATEMENT - CORPORATE by Purdue Pharma Inc . (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| 40 | 40
DISCLOSURE STATEMENT - CORPORATE by The Purdue Frederick Company . (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| Thursday, May 02, 2019 | ||
| 41 | 41
UNOPPOSED MOTION for Extension of Time to Answer or Otherwise Respond to Petition Under Rule 12 by Anda Inc, Anda Pharmaceuticals Inc. (Curran, Jeffrey) [Transferred from okwd on 8/23/2019.]
|
|
| 42 | 42
ORDER granting41 Anda Defendants' Unopposed Joint Motion to Extend Time to Answer, Move, or Otherwise Respond to Petition Under Rule 12. Signed by Honorable Stephen P. Friot on 5/2/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, May 03, 2019 | ||
| 43 | 43
MOTION to Remand by Enid City of.(Court, Todd) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - Order - Trotter v. Smith et al.,
|
||
|
Att: 2
Exhibit 2 - Order - Adams v. Wyeth
|
||
| Wednesday, May 15, 2019 | ||
| 44 | 44
MOTION to Expedite Treatment of Motion to Remand by Enid City of. (Sill, Matthew) [Transferred from okwd on 8/23/2019.]
|
|
| Wednesday, May 22, 2019 | ||
| 45 | 45
RESPONSE in Opposition re44 MOTION to Expedite Treatment of Motion to Remand filed by Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc, Watson Pharma Inc.(Evans, Kyle) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1-List of Cases
|
||
| 46 | 46
SUPPLEMENT Authority by Enid City of.(Sill, Matthew) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit A - Memorandum and Order re remand
|
||
| Thursday, May 23, 2019 | ||
| NOTICE from the Court re46 Plaintiff's Notice of Supplemental Authority. Counsel for plaintiff is DIRECTED, in future filings, to comply with the court's ECF Policies & Procedures Manual, Section II.A.4.a. - "Exhibits... shall be clearly labeled with the appropriate exhibit number.... Do not use alphabetical or alpha-numeric designations for exhibits...." Failure to comply in the future may result in filings being stricken. (llg) [Transferred from okwd on 8/23/2019.] | ||
| Friday, May 24, 2019 | ||
| 47 | 47
RESPONSE in Opposition re43 MOTION to Remand filed by Actavis LLC. (Evans, Kyle) [Transferred from okwd on 8/23/2019.]
|
|
| 48 | 48
RESPONSE in Opposition re43 MOTION to Remand filed by McKesson Corp.(Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit CTO,
|
||
|
Att: 2
Exhibit Statement of Interest,
|
||
|
Att: 3
Exhibit Withdrawal of Order
|
||
| 49 | 49
JOINT MOTION to Stay Case Pending Likely Transfer to Multidistrict Litigation by Amerisourcebergen Corp, Cardinal Health Inc, McKesson Corp.(Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit Ada Stay Order,
|
||
|
Att: 2
Exhibit Seminole Stay Order,
|
||
|
Att: 3
Exhibit Osage Stay Order,
|
||
|
Att: 4
Exhibit Pawnee stay Order,
|
||
|
Att: 5
Exhibit Delaware Stay Order,
|
||
|
Att: 6
Exhibit CTO,
|
||
|
Att: 7
Exhibit Wis. Stay Order,
|
||
|
Att: 8
Exhibit Cal. Stay Order,
|
||
|
Att: 9
Exhibit Ky. Stay Order,
|
||
|
Att: 10
Exhibit 6 County Transfer Order,
|
||
|
Att: 11
Exhibit County Transfer Order,
|
||
|
Att: 12
Exhibit Portland Stay Order,
|
||
|
Att: 13
Exhibit EDVA Stay Order,
|
||
|
Att: 14
Exhibit WDVA Stay Order,
|
||
|
Att: 15
Exhibit Cal. Stay Order,
|
||
|
Att: 16
Exhibit Ill. Stay Order,
|
||
|
Att: 17
Exhibit Fla. Deferral Order
|
||
| Friday, May 31, 2019 | ||
| 50 | 50
REPLY by Plaintiff Enid City of re43 MOTION to Remand filed by Enid City of. (Court, Todd) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, June 14, 2019 | ||
| 51 | 51
RESPONSE to Motion re49 JOINT MOTION to Stay Case Pending Likely Transfer to Multidistrict Litigation filed by Enid City of.(Court, Todd) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1-Order Regarding Remands [#130],
|
||
|
Att: 2
Exhibit 2-Case Management Order [#232]
|
||
| Wednesday, June 19, 2019 | ||
| 52 | 52
NOTICE OF BANKRUPTCY by Insys Therapeutic Inc and Imposition of Automatic Stay (Pierce, Amy) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, June 21, 2019 | ||
| 53 | 53
REPLY to Response to Motion re49 JOINT MOTION to Stay Case Pending Likely Transfer to Multidistrict Litigation filed by Amerisourcebergen Corp, Cardinal Health Inc, McKesson Corp.(Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - Hearing Order,
|
||
|
Att: 2
Exhibit 2 - Transfer Order,
|
||
|
Att: 3
Exhibit 3 - Alameda CA Stay Order
|
||
| Thursday, August 01, 2019 | ||
| 54 | 54
CONDITIONAL TRANSFER ORDER transferring case to District of Northern District of Ohio for coordinated or consolidated pretrial proceedings pursuant to 28 USC 1407 and assigned to the Honorable Dan A Polster. Signed by Clerk of the Panel. (ac) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, August 23, 2019 | ||
| 55 | 55
CASE TRANSFERRED IN from District of Oklahoma Western. Case number 5:19-cv-00351. Original file, certified copy of transfer order and docket sheet received.
|
|